Filing Details
- Accession Number:
- 0001415889-24-024093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-30 16:53:23
- Reporting Period:
- 2024-09-26
- Accepted Time:
- 2024-09-30 16:53:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230484 | A Lawrence Kenyon | C/O Outlook Therapeutics, Inc. 111 S. Wood Avenue, Unit #100 Iselin NJ 08830 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-26 | 5,000 | $5.69 | 5,946 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.
Billionaire Hedge Funds
